These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1995903)

  • 41. The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs.
    Matter WF; Brown RF; Vlahos CJ
    Biochem Biophys Res Commun; 1992 Jul; 186(2):624-31. PubMed ID: 1323287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases.
    Ono K; Nakane H; Fukushima M; Chermann JC; Barré-Sinoussi F
    Eur J Biochem; 1990 Jul; 190(3):469-76. PubMed ID: 1695572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phosphonate-containing inhibitors of tyrosine-specific protein kinases.
    Burke TR; Li ZH; Bolen JB; Marquez VE
    J Med Chem; 1991 May; 34(5):1577-81. PubMed ID: 2033582
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Raf-1 serine-threonine kinase is a substrate for the p56lck protein tyrosine kinase in human T-cells.
    Thompson PA; Ledbetter JA; Rapp UR; Bolen JB
    Cell Growth Differ; 1991 Dec; 2(12):609-17. PubMed ID: 1687313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity.
    Linassier C; Pierre M; Le Pecq JB; Pierre J
    Biochem Pharmacol; 1990 Jan; 39(1):187-93. PubMed ID: 2153378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pentasubstituted quercetin analogues as selective inhibitors of particulate 3':5'-cyclic-AMP phosphodiesterase from rat brain.
    Picq M; Prigent AF; Némoz G; André AC; Pacheco H
    J Med Chem; 1982 Oct; 25(10):1192-8. PubMed ID: 6292419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of p56lck, a lymphocyte specific protein tyrosine kinase, on the syncytium formation induced by human immunodeficiency virus envelope glycoprotein.
    Yoshida H; Koga Y; Moroi Y; Kimura G; Nomoto K
    Int Immunol; 1992 Feb; 4(2):233-42. PubMed ID: 1622897
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.
    Rewcastle GW; Palmer BD; Bridges AJ; Showalter HD; Sun L; Nelson J; McMichael A; Kraker AJ; Fry DW; Denny WA
    J Med Chem; 1996 Feb; 39(4):918-28. PubMed ID: 8632415
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and evaluation of multisubstrate inhibitors of an oncogene-encoded tyrosine-specific protein kinase. 1.
    Kruse CH; Holden KG; Pritchard ML; Feild JA; Rieman DJ; Greig RG; Poste G
    J Med Chem; 1988 Sep; 31(9):1762-7. PubMed ID: 2970550
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Murine T-lymphocyte proliferation induced by interleukin 2 correlates with a transient increase in p56lck kinase activity and the tyrosine phosphorylation of a 97-kDa protein.
    Kim YH; Buchholz MJ; Nordin AA
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3187-91. PubMed ID: 7682694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of protein tyrosine phosphatase 1B by flavonoids: A structure - activity relationship study.
    Proença C; Freitas M; Ribeiro D; Sousa JLC; Carvalho F; Silva AMS; Fernandes PA; Fernandes E
    Food Chem Toxicol; 2018 Jan; 111():474-481. PubMed ID: 29175190
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-amine based analogues of lavendustin A as protein-tyrosine kinase inhibitors.
    Smyth MS; Stefanova I; Hartmann F; Horak ID; Osherov N; Levitzki A; Burke TR
    J Med Chem; 1993 Oct; 36(20):3010-4. PubMed ID: 8105084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. T-lymphocyte interleukin 2-dependent tyrosine protein kinase signal transduction involves the activation of p56lck.
    Horak ID; Gress RE; Lucas PJ; Horak EM; Waldmann TA; Bolen JB
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1996-2000. PubMed ID: 2000405
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and tyrosine kinase inhibitory activity of a series of 2-amino-8H-pyrido[2,3-d]pyrimidines: identification of potent, selective platelet-derived growth factor receptor tyrosine kinase inhibitors.
    Boschelli DH; Wu Z; Klutchko SR; Showalter HD; Hamby JM; Lu GH; Major TC; Dahring TK; Batley B; Panek RL; Keiser J; Hartl BG; Kraker AJ; Klohs WD; Roberts BJ; Patmore S; Elliott WL; Steinkampf R; Bradford LA; Hallak H; Doherty AM
    J Med Chem; 1998 Oct; 41(22):4365-77. PubMed ID: 9784112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct inhibition of the hexose transporter GLUT1 by tyrosine kinase inhibitors.
    Vera JC; Reyes AM; Velásquez FV; Rivas CI; Zhang RH; Strobel P; Slebe JC; Núñez-Alarcón J; Golde DW
    Biochemistry; 2001 Jan; 40(3):777-90. PubMed ID: 11170395
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tyrosine kinase inhibitors. 3. Structure-activity relationships for inhibition of protein tyrosine kinases by nuclear-substituted derivatives of 2,2'-dithiobis(1-methyl-N-phenyl-1H-indole-3-carboxamide).
    Rewcastle GW; Palmer BD; Dobrusin EM; Fry DW; Kraker AJ; Denny WA
    J Med Chem; 1994 Jun; 37(13):2033-42. PubMed ID: 8027985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quinazoline antifolate thymidylate synthase inhibitors: alkyl, substituted alkyl, and aryl substituents in the C2 position.
    Hughes LR; Jackman AL; Oldfield J; Smith RC; Burrows KD; Marsham PR; Bishop JA; Jones TR; O'Connor BM; Calvert AH
    J Med Chem; 1990 Nov; 33(11):3060-7. PubMed ID: 2231606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design, synthesis and biological activity of flavonoid derivatives as selective agonists for neuromedin U 2 receptor.
    Ma ML; Li M; Gou JJ; Ruan TY; Jin HS; Zhang LH; Wu LC; Li XY; Hu YH; Wen K; Zhao Z
    Bioorg Med Chem; 2014 Nov; 22(21):6117-23. PubMed ID: 25262941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor.
    Rewcastle GW; Denny WA; Bridges AJ; Zhou H; Cody DR; McMichael A; Fry DW
    J Med Chem; 1995 Sep; 38(18):3482-7. PubMed ID: 7658435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibitors of farnesyl protein transferase and MEK1,2 induce apoptosis in fibroblasts transformed with farnesylated but not geranylgeranylated H-Ras.
    Brassard DL; English JM; Malkowski M; Kirschmeier P; Nagabhushan TL; Bishop WR
    Exp Cell Res; 2002 Feb; 273(2):138-46. PubMed ID: 11822869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.